Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials von Grossberg, George T., Kohegyi, Eva, Mergel, Victor, Josiassen, Mette Krog, Meulien, Didier, Hobart, Mary, Slomkowski, Mary, Baker, Ross A., McQuade, Robert D., Cummings, Jeffrey L.

Volltext

Nalmefene in alcohol‐dependent patients with a high drinking risk: Randomized controlled trial von Miyata, Hisatsugu, Takahashi, Masayoshi, Murai, Yoshiyuki, Tsuneyoshi, Kana, Hayashi, Takako, Meulien, Didier, Sørensen, Per, Higuchi, Susumu

Volltext

Long‐term safety and efficacy of nalmefene in Japanese patients with alcohol dependence von Higuchi, Susumu, Takahashi, Masayoshi, Murai, Yoshiyuki, Tsuneyoshi, Kana, Nakamura, Izuru, Meulien, Didier, Miyata, Hisatsugu

Volltext

A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease von Rascol, Olivier, Medori, Rossella, Baayen, Corine, Such, Pedro, Meulien, Didier

Volltext

Diagnostic criteria for apathy in neurocognitive disorders von Miller, David S., Robert, Philippe, Ereshefsky, Larry, Adler, Lawrence, Bateman, Daniel, Cummings, Jeff, DeKosky, Steven T., Fischer, Corinne E., Husain, Masud, Ismail, Zahinoor, Jaeger, Judith, Lerner, Alan J., Li, Abby, Lyketsos, Constantine G., Manera, Valeria, Mintzer, Jacobo, Moebius, Hans J., Mortby, Moyra, Meulien, Didier, Pollentier, Stephane, Porsteinsson, Anton, Rasmussen, Jill, Rosenberg, Paul B., Ruthirakuhan, Myuri T., Sano, Mary, Zucchero Sarracini, Carla, Lanctôt, Krista L.

Volltext

Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population von Hasin, Deborah S, Prof, Wall, Melanie, Prof, Witkiewitz, Katie, Prof, Kranzler, Henry R, Prof, Falk, Daniel, PhD, Litten, Raye, PhD, Mann, Karl, Prof, O'Malley, Stephanie S, Prof, Scodes, Jennifer, MS, Robinson, Rebecca L, MS, Anton, Raymond, Prof

Volltext

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials von Falk, Daniel E, O’Malley, Stephanie S, Witkiewitz, Katie, Anton, Raymond F, Litten, Raye Z, Slater, Megan, Kranzler, Henry R, Mann, Karl F, Hasin, Deborah S, Johnson, Bankole, Meulien, Didier, Ryan, Megan, Fertig, Joanne

Volltext

Randomized Phase I Trial of the α‐Synuclein Antibody Lu AF82422 von Buur, Louise, Wiedemann, Jonas, Larsen, Frank, Ben Alaya‐Fourati, Fayrouz, Kallunki, Pekka, Ditlevsen, Dorte Kornerup, Sørensen, Mette Høgh, Meulien, Didier

Volltext

Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis von Mueller, Sebastian, Luderer, Mathias, Zhang, Doris, Meulien, Didier, Brach, Björn Steiniger, Schou, Maiken Brix

Volltext

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort von Marek, Kenneth, Chowdhury, Sohini, Siderowf, Andrew, Lasch, Shirley, Coffey, Christopher S., Jennings, Danna, Tanner, Caroline M., Singleton, Andrew, Mollenhauer, Brit, Galasko, Doug, Chahine, Lana M., Weintraub, Daniel, Foroud, Tatiana, Tosun‐Turgut, Duygu, Poston, Kathleen, Frasier, Mark, Merchant, M, Kopil, Catherine, Naito, Anna, Dorsey, Ray, Casaceli, Cynthia, Daegele, Nichole, Foster, Eric, Long, Jeff, Crawford, Karen, Casalin, Paola, Malferrari, Giulia, Halter, Cheryl, Heathers, Laura, Russell, David, Jankovic, Joseph, Hu, Shu‐Ching, Richard, Irene, Saint‐Hilaire, H, Seppi, Klaus, Trenkwalder, Claudia, Oertel, Wolfgang, Brockman, Kathrin, Wurster, Isabel, Rosenthal, Liana, Pavese, Nicola, Barone, Paolo, Isaacson, Stuart, Espay, Alberto, Rowe, Dominic, Brandabur, Melanie, Liang, Grace, Tolosa, Eduardo, Marder, Karen, Sanchez, Maria, Stefanis, Leonidis, Marti, Maria, Corvol, Jean‐Christophe, Assly, O, Brillman, Salima, Giladi, Nir, Pelaggi, Julia, Williams, Karen, Guthrie, Stephanie, Hunter, Christine, Deritis, Paul, Raymond, Deborah, Obradov, Zoran, Mule, Jennifer, Monahan, Nancy, McCoy, Arita, Payne, Laura, Ainscough, Susan, Silverstein, Rebecca, Espay, Kristy, Rezola, Elisabet, Stamelou, Maria, Carvalho, Stephanie, Kristiansen, Grete, Mirlman, Anat, Facheris, Maurizio, Soares, Holly, Mintun, A, Taylor, Peggy, Jennings, Danna, Slieker, Lawrence, McBride, Brian, Watson, Colin, Montagut, Etienne, Fischer, Tanya, Reith, D, Egebjerg, Jan, Larsen, Lone, Breysse, Nathalie, Saba, Barbara, Kiyasova, Vera, Min, Chris, McAvoy, Thomas, Umek, Robert, Iredale, Philip, Santi, De, Boess, Frank, Sevigny, Jeffrey, Stewart, Alexandra, Prashad, Rene

Volltext

Methods to Analyze Treatment Effects in the Presence of Missing Data for a Continuous Heavy Drinking Outcome Measure When Participants Drop Out from Treatment in Alcohol Clinical T... von Witkiewitz, Katie, Falk, Daniel E., Kranzler, Henry R., Litten, Raye Z., Hallgren, Kevin A., O'Malley, Stephanie S., Anton, Raymond F.

Volltext

Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study von Quelch, Darren R, Mick, Inge, McGonigle, John, Ramos, Anna C, Flechais, Remy S.A, Bolstridge, Mark, Rabiner, Eugenii, Wall, Matthew B, Newbould, Rexford D, Steiniger-Brach, Björn, van den Berg, Franz, Boyce, Malcolm, Østergaard Nilausen, Dorrit, Breuning Sluth, Lasse, Meulien, Didier, von der Goltz, Christoph, Nutt, David, Lingford-Hughes, Anne

Volltext

Safety and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double-blind, placebo-controlled studies von Meulien, Didier, Huizar, Karin, Brecher, Martin

Volltext

Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care von Castera, Philippe, Stewart, Edmund, Großkopf, Josef, Brotons, Carlos, Schou, Maiken Brix, Zhang, Doris, Brach, Björn Steiniger, Meulien, Didier

Volltext

The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders von Anton, Raymond F, Litten, Raye Z, Falk, Daniel E, Palumbo, Joseph M, Bartus, Raymond T, Robinson, Rebecca L, Kranzler, Henry R, Kosten, Thomas R, Meyer, Roger E, O'Brien, Charles P, Mann, Karl, Meulien, Didier

Volltext

What happens when people discontinue taking medications? Lessons from COMBINE von Stout, Robert L., Braciszewski, Jordan M., Subbaraman, Meenakshi Sabina, Kranzler, Henry R., O'Malley, Stephanie S., Falk, Daniel

Volltext

Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials von Falk, Daniel E, Litten, Raye Z, Anton, Raymond F, Kranzler, Henry R, Johnson, Bankole A

Volltext

Apolipoprotein E and Alzheimer disease : Genotype-specific risks by age and sex von BICKEBÖLLER, H, CAMPION, D, DUBOIS, B, LEDOZE, F, THOMAS-ANTERION, C, PASQUIER, F, PUEL, M, DEMONET, J.-F, MOREAUD, O, BABRON, M.-C, MEULIEN, D, GUEZ, D, BRICE, A, CHARTIER-HARLIN, B. M.-C, FREBOURG, T, AGID, Y, MARTINEZ, M, CLERGET-DARPOUX, F, AMOUYEL, P, HANNEQUIN, D, DIDIERJEAN, O, PENET, C, MARTIN, C, PEREZ-TUR, J, MICHON, A

Volltext

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Al... von Dubois, Bruno, McKeith, Ian, Orgogozo, Jean-Marc, Collins, Owen, Meulien, Didier

Volltext

NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS von ABBARIKI, Afsaneh, SORENSEN, Per, JENSEN, Thomas, Ostergaard, Jette, TORUP, Lars, MEULIEN, Didier, BLADSTROEM, Anna, PERSSON, Christine

Volltext bestellen